Viewing Study NCT01296256

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:16 PM
Ignite Modification Date: 2026-01-03 @ 10:49 AM
Study NCT ID: NCT01296256
Status: COMPLETED
Last Update Posted: 2016-02-17
First Post: 2011-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL).
Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bendamustine View
None Conditioning Therapy View
None Autologous Stem Cell Transplant View
None Aggressive Non Hodgkin's Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bendamustine View
None Conditioning Therapy View
None Autologous Stem Cell Transplant View
None Aggressive Non Hodgkin's Lymphoma View